# OLIG2

## Overview
OLIG2 is a gene that encodes the oligodendrocyte transcription factor 2, a basic helix-loop-helix (bHLH) transcription factor that plays a pivotal role in the development of the central nervous system. The protein is crucial for the differentiation and maturation of oligodendrocytes and motor neurons, acting as both a transcriptional activator and repressor depending on the cellular context. OLIG2's function is modulated by its phosphorylation state, which affects its localization and interaction with other proteins, such as the tumor suppressor p53. This transcription factor is involved in various protein-protein interactions, forming complexes with other bHLH proteins and homeodomain proteins to regulate gene expression during neural development. Clinically, OLIG2 is significant in the context of brain tumors, particularly gliomas, where its expression is associated with tumor proliferation and resistance to therapy. Additionally, OLIG2 has been implicated in neurological diseases such as amyotrophic lateral sclerosis (ALS), highlighting its broader impact on neural pathophysiology (Behling2020Expression; Meijer2014An; Satoh2015A).

## Structure
OLIG2 is a basic helix-loop-helix (bHLH) transcription factor involved in neural development. The primary structure of OLIG2 includes a bHLH domain, which is essential for DNA binding and dimerization, allowing it to interact with specific DNA elements and other proteins (Sun2003CrossRepressive). This domain is crucial for its interaction with other transcription factors, such as Nkx2.2, and is necessary for its cross-repressive functions (Sun2003CrossRepressive).

The secondary structure of OLIG2 is characterized by the presence of alpha helices within the bHLH domain, which facilitate its structural integrity and function. The tertiary structure involves the three-dimensional folding that allows OLIG2 to interact with other proteins and DNA effectively. OLIG2 can form heterodimers with other bHLH proteins, such as Tcf12 and Olig1, indicating a quaternary structure involving multiple subunits (Meijer2014An).

Post-translational modifications, particularly phosphorylation, play a significant role in regulating OLIG2's activity. Phosphorylation of specific serine and threonine residues, including a triple serine motif, influences its intranuclear localization and transcriptional activity (Meijer2014An; Meijer2012Separated). These modifications are critical for its role in cell proliferation and differentiation, as well as its interaction with other proteins like p53 (Meijer2014An).

## Function
OLIG2 (oligodendrocyte transcription factor 2) is a basic helix-loop-helix transcription factor that plays a crucial role in the development of the central nervous system, particularly in the formation of oligodendrocytes and motor neurons. In neural progenitor cells, OLIG2 is involved in both promoting proliferation and facilitating differentiation. It acts as a transcriptional repressor by binding to E-box elements in DNA, such as in the promoter of the Hb9 gene, to maintain the replication-competent state of neural progenitors and prevent premature differentiation into motor neurons (Meijer2012Separated).

OLIG2 also regulates the expression of long non-coding RNAs (lncRNAs) during oligodendrocyte differentiation, acting as both an activator and repressor of gene expression. This regulation is crucial for the transition from neural stem cells to oligodendrocyte precursor cells and further to newly formed oligodendrocytes (Wei2021OLIG2). OLIG2's function is modulated by its phosphorylation state, which influences its intranuclear compartmentalization and interaction with other proteins, such as the tumor suppressor p53. Phosphorylated OLIG2 is associated with transcriptionally active chromatin, while nonphosphorylated OLIG2 is found in both active and inactive chromatin compartments (Meijer2014An).

## Clinical Significance
Alterations in the expression of the OLIG2 gene have significant clinical implications, particularly in the context of brain tumors. OLIG2 is highly expressed in gliomas, including glioblastomas, where it is associated with the presence of glioma stem cells, which are resistant to therapy and contribute to tumor recurrence and invasion (Behling2020Expression; Ligon2007Olig2-Regulated). In diffuse intrinsic pontine gliomas (DIPGs), OLIG2 expression is linked to a shorter median overall survival, and its silencing can inhibit tumor cell viability, suggesting its critical role in tumor proliferation (Anderson2017The).

OLIG2 also plays a role in the pathogenesis of amyotrophic lateral sclerosis (ALS). Overactivation of OLIG2 and subsequent repression of its target genes may contribute to motor neuron degeneration in ALS, highlighting its potential involvement in neurological diseases beyond cancer (Satoh2015A).

In gliomas, OLIG2 is involved in oncogenic pathways, including the repression of tumor suppressor genes like p53, contributing to resistance against radiation and genotoxic drugs (Szu2023Biological). These findings underscore the potential of targeting OLIG2 for therapeutic interventions in gliomas and other related conditions (Ligon2007Olig2-Regulated).

## Interactions
OLIG2, a basic helix-loop-helix (bHLH) transcription factor, participates in various protein-protein interactions that are crucial for its role in neural development. OLIG2 forms complexes with ID proteins, specifically ID2 and ID4, which act as dominant-negative inhibitors by preventing OLIG2 from binding to DNA and translocating to the nucleus. This interaction is enhanced by BMP4 treatment, which increases ID protein expression, leading to the cytoplasmic sequestration of OLIG2 and inhibition of oligodendrocyte development (Samanta2004Interactions).

OLIG2 also interacts with E2A proteins, such as E12 and E47, forming heterodimers that can bind to E-box elements in DNA, influencing gene expression in motor neuron progenitor cells. These interactions are essential for the regulation of genes like Hb9, where OLIG2 acts as a transcriptional repressor (Lee2005Olig2).

Additionally, OLIG2 forms a specific complex with the homeodomain protein Nkx2.2, mediated by the bHLH domain of OLIG2 and the homeodomain of Nkx2.2. This interaction plays a role in neural development by inhibiting the induction of certain genes, such as Sim1, in the developing neural tube (Sun2003CrossRepressive).


## References


[1. (Meijer2014An) D. H. Meijer, Y. Sun, T. Liu, M. F. Kane, J. A. Alberta, G. Adelmant, R. Kupp, J. A. Marto, D. H. Rowitch, Y. Nakatani, C. D. Stiles, and S. Mehta. An amino terminal phosphorylation motif regulates intranuclear compartmentalization of olig2 in neural progenitor cells. Journal of Neuroscience, 34(25):8507–8518, June 2014. URL: http://dx.doi.org/10.1523/jneurosci.0309-14.2014, doi:10.1523/jneurosci.0309-14.2014. This article has 21 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1523/jneurosci.0309-14.2014)

[2. (Wei2021OLIG2) Haichao Wei, Xiaomin Dong, Yanan You, Bo Hai, Raquel Cuevas-Diaz Duran, Xizi Wu, Natasha Kharas, and Jia Qian Wu. Olig2 regulates lncrnas and its own expression during oligodendrocyte lineage formation. BMC Biology, June 2021. URL: http://dx.doi.org/10.1186/s12915-021-01057-6, doi:10.1186/s12915-021-01057-6. This article has 14 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1186/s12915-021-01057-6)

[3. (Anderson2017The) Jane L. Anderson, Ranjithmenon Muraleedharan, Nicole Oatman, Amanda Klotter, Satarupa Sengupta, Ronald R. Waclaw, Jianqiang Wu, Rachid Drissi, Lili Miles, Eric H. Raabe, Matthew L. Weirauch, Maryam Fouladi, Lionel M. Chow, Lindsey Hoffman, Mariko DeWire, and Biplab Dasgupta. The transcription factor olig2 is important for the biology of diffuse intrinsic pontine gliomas. Neuro-Oncology, 19(8):1068–1078, February 2017. URL: http://dx.doi.org/10.1093/neuonc/now299, doi:10.1093/neuonc/now299. This article has 33 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1093/neuonc/now299)

[4. (Szu2023Biological) Jenny I. Szu, Igor F. Tsigelny, Alexander Wojcinski, and Santosh Kesari. Biological functions of the olig gene family in brain cancer and therapeutic targeting. Frontiers in Neuroscience, May 2023. URL: http://dx.doi.org/10.3389/fnins.2023.1129434, doi:10.3389/fnins.2023.1129434. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fnins.2023.1129434)

[5. (Behling2020Expression) Felix Behling, Alonso Barrantes-Freer, Carl Ludwig Behnes, Florian Stockhammer, Veit Rohde, Antonia Adel-Horowski, Odir Antonio Rodríguez-Villagra, Miguel Angel Barboza, Wolfgang Brück, Ulrich Lehmann, Christine Stadelmann, and Christian Hartmann. Expression of olig2, nestin, nogoa and aqp4 have no impact on overall survival in idh-wildtype glioblastoma. PLOS ONE, 15(3):e0229274, March 2020. URL: http://dx.doi.org/10.1371/journal.pone.0229274, doi:10.1371/journal.pone.0229274. This article has 10 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0229274)

[6. (Lee2005Olig2) Soo-Kyung Lee, Bora Lee, Esmeralda C. Ruiz, and Samuel L. Pfaff. Olig2 and ngn2 function in opposition to modulate gene expression in motor neuron progenitor cells. Genes &amp; Development, 19(2):282–294, January 2005. URL: http://dx.doi.org/10.1101/gad.1257105, doi:10.1101/gad.1257105. This article has 267 citations.](https://doi.org/10.1101/gad.1257105)

[7. (Samanta2004Interactions) Jayshree Samanta and John A. Kessler. Interactions between id and olig proteins mediate the inhibitory effects of bmp4 on oligodendroglial differentiation. Development, 131(17):4131–4142, September 2004. URL: http://dx.doi.org/10.1242/dev.01273, doi:10.1242/dev.01273. This article has 452 citations and is from a peer-reviewed journal.](https://doi.org/10.1242/dev.01273)

[8. (Sun2003CrossRepressive) Tao Sun, Hualing Dong, Lizi Wu, Michael Kane, David H. Rowitch, and Charles D. Stiles. Cross-repressive interaction of the olig2 and nkx2.2 transcription factors in developing neural tube associated with formation of a specific physical complex. The Journal of Neuroscience, 23(29):9547–9556, October 2003. URL: http://dx.doi.org/10.1523/jneurosci.23-29-09547.2003, doi:10.1523/jneurosci.23-29-09547.2003. This article has 61 citations.](https://doi.org/10.1523/jneurosci.23-29-09547.2003)

[9. (Meijer2012Separated) Dimphna H. Meijer, Michael F. Kane, Shwetal Mehta, Hongye Liu, Emily Harrington, Christopher M. Taylor, Charles D. Stiles, and David H. Rowitch. Separated at birth? the functional and molecular divergence of olig1 and olig2. Nature Reviews Neuroscience, 13(12):819–831, November 2012. URL: http://dx.doi.org/10.1038/nrn3386, doi:10.1038/nrn3386. This article has 133 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/nrn3386)

[10. (Ligon2007Olig2-Regulated) Keith L. Ligon, Emmanuelle Huillard, Shwetal Mehta, Santosh Kesari, Hongye Liu, John A. Alberta, Robert M. Bachoo, Michael Kane, David N. Louis, Ronald A. DePinho, David J. Anderson, Charles D. Stiles, and David H. Rowitch. Olig2-regulated lineage-restricted pathway controls replication competence in neural stem cells and malignant glioma. Neuron, 53(4):503–517, February 2007. URL: http://dx.doi.org/10.1016/j.neuron.2007.01.009, doi:10.1016/j.neuron.2007.01.009. This article has 398 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.neuron.2007.01.009)

[11. (Satoh2015A) Jun-Ichi Satoh, Naohiro Asahina, Shouta Kitano, and Yoshihiro Kino. A comprehensive profile of chip-seq-based olig2 target genes in motor neuron progenitor cells suggests the possible involvement of olig2 in the pathogenesis of amyotrophic lateral sclerosis. Journal of Central Nervous System Disease, 7:JCNSD.S23210, January 2015. URL: http://dx.doi.org/10.4137/JCNSD.S23210, doi:10.4137/jcnsd.s23210. This article has 18 citations and is from a peer-reviewed journal.](https://doi.org/10.4137/JCNSD.S23210)